Efficacy and safety of rituximab in the treatment of refractory myasthenia gravis: Meta-analysis

Efficacy and safety of rituximab in the treatment of refractory myasthenia gravis: Meta-analysis

Objective To evaluate the efficacy and safety of rituximab (RTX) in the treatment of refractory myasthenia gravis (MG). Methods Retrieve relevant retrospective case analysis and observational studies that reported RTX therapy in patients with refractory MG from online databases (January 1, 2000-Apri...

Full description

Bibliographic Details
Main Authors: Shan-shan CHU, Deng CHEN, Li-na ZHU, Ge TAN, Da XU, Hai-jiao WANG, Yu ZHANG, Ling LIU
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2018-07-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Myasthenia gravis
Receptors, cholinergic
Receptor protein ⁃ tyrosine kinases
Meta⁃analysis
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/1808

Internet

http://www.cjcnn.org/index.php/cjcnn/article/view/1808

Similar Items